Category Archives: RESEARCH, STUDIES, DOCUMENTATION

Embalmer pulling out vaccine induced rubbery CLOT from Jugular vein

I cannot embed this video.  To see the video click the link below for the article and for the one minute video of the embalmer pulling out the clots caused by the Covid vaccine.

READ ARTICLE AND SEE VIDEO

 

Embalmers find rubbery blood clots in vaccine injected autopsies

In a recent survey of 269 embalmers across four major countries and three continents, more than 70% reported finding strange fibrous white blood clots in significant percentages of corpses in 2023 — clots they were not finding pre-pandemic.

A similar survey conducted in late 2022 revealed that 66% of embalmers began finding the unusual clots in mid-2021, suggesting a temporal link to the rollout of COVID-19 vaccines, which began earlier that year. READ MORE…

Parkinson Disease (some links)

Parkinson’s disease (PD), or simply Parkinson’s, is a chronic degenerative disorder of the central nervous system that affects both the motor system and non-motor systems. The symptoms usually emerge slowly, and as the disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognitio.

Chemicals in the environment

Is Parkinson genetic?

Mitochondrial DNA damage and Parkinson

Vaccines linked to Parkinson Disease

VLA COMMENT:  If the Covid Vaccine is linked to Parkinson and Dementia, think of all the childhood vaccines with mercury and aluminum. As well, vaccines damage the mitochondria. A study I once read authored by some head Doctor at a big medical University suggests that his work shows that all mentally ill people have damaged mitochondria. Which came first, the chicken or the egg>

 

 

Miracle Drug (Ivermectin)…the True Story of Ivermectin

Historical Context and Uses

Originally developed by Merck & Co. in the late 1970s, Ivermectin was first used as a veterinary drug against worms in animals. In humans, its primary utility has been in the treatment of diseases caused by parasitic worms, like onchocerciasis (river blindness) and lymphatic filariasis. Due to its efficacy against these diseases, the World Health Organization (WHO) has listed Ivermectin on its list of essential medicines.

The Pioneers Behind Ivermectin:

The development of Ivermectin was not just a monumental leap in the field of medicine; it was also a testament to the perseverance and innovation of two eminent scientists – Dr. William C. Campbell and Professor Satoshi Ōmura.

Satoshi Ōmura: A distinguished Japanese microbiologist and bioorganic chemist, Professor Ōmura’s work primarily focused on isolating naturally occurring microbes from the soil. His belief in the potential therapeutic applications of these microbes led him to identify and cultivate a unique strain of bacteria called *Streptomyces avermitilis*. This strain proved to be the foundation for the creation of Ivermectin.

William C. Campbell: An Irish-born biologist, Dr. Campbell’s insights into the realm of parasitic diseases were pivotal. Working with Merck Institute for Therapeutic Research, Campbell identified the antiparasitic properties of the compounds derived from Professor Ōmura’s bacterial strain. This collaboration eventually led to the development and commercial production of Ivermectin.

Awards and Recognition:

Their combined efforts culminated not only in the creation of a groundbreaking drug but also in accolades that celebrated their contribution to humankind. In 2015, their discoveries were honored with the Nobel Prize in Physiology or Medicine. The Nobel Assembly at the Karolinska Institute awarded half of the prize to Ōmura and Campbell, recognizing their work in developing a therapy against infections caused by roundworm parasites. Their discovery of Ivermectin and its applications brought about significant reductions in the incidence of river blindness and lymphatic filariasis, profoundly impacting global health.

Their legacy stands as a reminder of the transformative impact of scientific collaboration and exploration. Ivermectin, as a result of their combined endeavors, has and continues to bring relief to millions of individuals plagued by debilitating diseases worldwide.

READ MORE: 

 

VLA COMMENT: GREAT READ!

Mayo Study: Vaccines and Pharmacogenetics

Abstract
The field of pharmacogenomics and pharmacogenetics provides a promising science base for vaccineresearch and development. A broad range of phenotype/genotype data combined with high through put genetic sequencing and bioinformatics are increasingly being integrated into this emerging field of vaccinomics. This paper discusses the hypothesis of the ‘immune response gene network’ and genetic (and bioinformatic) strategies to study associations between immune response gene polymorphisms and variations in humoral and cellular immune responses to prophylactic viral vaccines, such as measles–mumps–rubella, influenza, HIV, hepatitis B and smallpox. Immunogenetic studies reveal promising new vaccine targets by providing a better understanding of the mechanisms by which gene polymorphisms may influence innate and adaptive immune responses to vaccines, including vaccine failure and vaccine-associated adverse events. Additional benefits from vaccinomic studies include the development of personalized vaccines, the development of novel vaccines and the development of novel vaccine adjuvants.

pharmacogenomics_to_vacci-1 MAYO CLINIC STUDY

STUDY-Oral Zinc Sulfate for HPV: Disappearance of all warts

One month after the conclusion of treatment, a dermatologist reevaluated the patients. Response to treatment was defined as disappearance of all warts without residual scarring. All patients were followed for recurrence for 6 months after the completion of the treatment. P < .05 was considered statistically significant.

READ MORE…

 

Tylenol Use in Babies, Children After Vaccination Raises Risk of Autism, New Review Shows

The authors of a new review of the drug acetaminophen (paracetamol), sold under the brand names Tylenol and Panadol, called for the immediate end of the use of the drug in infants and children, citing the drug’s association with autism spectrum disorder (ASD).

“Our study shows that acetaminophen would never be approved for pediatric use by today’s regulatory standards,” Dr. William Parker, of WPLab, Inc., who led the research team that conducted the review on acetaminophen and autism, told The Defender.

READ MORE…